So having some vaccines available for the prevention of RSV in older persons, is really a great advance.
The single-dose vaccine works by blocking a key protein that helps the virus to invade human cells.
These serious adverse events were rare, representing one case for every 9,000 participants.
Luis Alvarez / Getty Images
However, thats higher than the one to two people per 100,000 typically diagnosed with Guillain-Barre each year.
The panel voted 7-4 to recommend the vaccines approval.
Young children were hit particularly hard in the last RSV season.
There are more RSV vaccines in the pipeline for older adults, too.
Modernasaidit expects to submit data on its mRNA vaccine for RSV in seniors in the next few months.
Bavarian Nordic also said it will report results from a phase 3 trial of its vaccine this year.
Vaccines dont prevent diseasevaccination prevents disease, Schaffner said.
That will be a challenge going forward.
FDA approves ABRYSVO, Pfizers vaccine for the prevention of respiratory syncytial virus (RSV) in older adults.
Centers for Disease Control and Prevention.Respiratory syncytial virus infection: RSV-NET interactive dashboard.
Centers for Disease Control and Prevention.RSV surveillance and research.
Centers for Disease Control and Prevention.Respiratory syncytial virus-associated mortality (RSV-associated mortality).
2023;388(7):595-608. doi:10.1056/NEJMoa2209604
